OncoSec Medical Incorporated Cash and Cash Equivalents 2011-2026 | ONCS

Annual Cash and Cash Equivalents OncoSec Medical Incorporated

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.7 M	46 M	20.4 M	25.1 M	3.8 M	11.4 M	28.7 M	32 M	37.9 M	4.97 M	5.14 M	2.46 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
46 M	2.46 M	18.7 M

Quarterly Cash and Cash Equivalents OncoSec Medical Incorporated

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
25.2 M	-	17.3 M	22.1 M	60.3 M	35.7 M	46 M	46 M	9.26 M	24 M	20.4 M	20.4 M	24.5 M	16.9 M	25.1 M	25.1 M	17.9 M	19 M	3.8 M	3.8 M	20.5 M	14.7 M	11.4 M	21.4 M	28.8 M	24.4 M	28.7 M	24.4 M	30.7 M	26.9 M	32 M	26.9 M	18.5 M	34 M	37.9 M	34 M	8.98 M	15.2 M	4.97 M	15.2 M	456 K	3.53 M	5.14 M	3.53 M	3.69 K	1.41 M	2.46 M	1.41 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
60.3 M	3.69 K	20 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.73	-	$ 8.97 B	Australia
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	1.66 B	$ 333.39	-	$ 43.7 B	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Burford Capital Limited BUR	322 M	$ 4.73	-	$ 784 M	Britain
Cabaletta Bio CABA	83 M	$ 3.4	-	$ 342 M	USA
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	18.3 M	$ 7.42	-	$ 73.3 M	USA
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 3.17	-	$ 5.22 M	Israel
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	29 K	-	-2.5 %	$ 5.88 M	USA
CNS Pharmaceuticals CNSP	7.2 M	$ 2.75	4.16 %	$ 1.22 M	USA
Amphastar Pharmaceuticals AMPH	170 M	$ 21.68	-	$ 1.01 B	USA
CymaBay Therapeutics CBAY	207 M	-	-	$ 3.45 B	USA
BioNTech SE BNTX	7.68 B	$ 99.47	-	$ 27.2 B	Germany
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	8.91 M	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	185 M	$ 1.55	-	$ 399 M	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	121 M	$ 4.24	-	$ 453 M	USA
Galectin Therapeutics GALT	17.7 M	$ 2.56	-	$ 164 M	USA
Arcutis Biotherapeutics ARQT	42.9 M	$ 24.58	-	$ 3.13 B	USA
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
Genmab A/S GMAB	3.55 B	$ 29.3	-	$ 18.8 B	Danmark
Autolus Therapeutics plc AUTL	104 M	$ 1.49	-	$ 397 M	Britain
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	6.6 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	16.2 M	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	28.9 M	$ 33.87	-	$ 2.25 B	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	28.9 M	-	-	$ 25.3 M	USA